Picking up the opening post: that is the part I would want checked first.
Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the current control status, not on the compound alone.
Picking up post #16: that is the part I would want checked first.
Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific medications and doses with a clinician familiar with bariatric surgery is prudent.
Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the current control status, not on the compound alone.
Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents, not a replacement for them.
Worth separating two things that post #50 runs together.
PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is thin; most discussion is by mechanism.
Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not independent variables.
Read the full topic (59 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Chronic kidney disease and the FLOW result — a second dataset
Chronic kidney disease and the FLOW result — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice about my own care —…
|
2 | 2.3k | 20mo | |
|
Hypertension improvement and when medication needs revisiting — a second dataset
Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that. General question, not a request for…
|
+126 | 133 | 22k | 21mo |
|
Hypertension improvement and when medication needs revisiting
Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+74 | 79 | 1.1k | 10mo |
|
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
4 | 12k | 5mo | |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. General question, not a request for advice about my own care…
|
+4 | 8 | 43k | 17mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Getting a referral rather than a refusal
Getting a referral rather than a refusal — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the difference and I would…
|
+8 | 12 | 32k | 2mo |
|
Second opinions: how to seek one without burning the first
Second opinions: how to seek one without burning the first Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice about my own care — I…
|
+1 | 5 | 33k | 19mo |
|
Sleep quality changes during weight loss — what changed since
Sleep quality changes during weight loss — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+68 | 74 | 10k | 8mo |
|
Coming back to: Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. General question, not a request for advice about my own care — I…
|
+139 | 151 | 47k | 18mo |
|
Why semaglutide solutions can look faintly opalescent and when that matters
The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med ,…
|
+73 | 79 | 2k | 4mo |